These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Scobie HM; Rainey GJ; Bradley KA; Young JA Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348 [TBL] [Abstract][Full Text] [Related]
6. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2. Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508 [TBL] [Abstract][Full Text] [Related]
7. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490 [TBL] [Abstract][Full Text] [Related]
8. Receptor-specific requirements for anthrax toxin delivery into cells. Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341 [TBL] [Abstract][Full Text] [Related]
9. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein. Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167 [TBL] [Abstract][Full Text] [Related]
10. Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay. Cryan LM; Habeshian KA; Caldwell TP; Morris MT; Ackroyd PC; Christensen KA; Rogers MS J Biomol Screen; 2013 Jul; 18(6):714-25. PubMed ID: 23479355 [TBL] [Abstract][Full Text] [Related]
11. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution. Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of anthrax protective antigen outside and inside the cell. Backer MV; Patel V; Jehning BT; Claffey KP; Karginov VA; Backer JM Antimicrob Agents Chemother; 2007 Jan; 51(1):245-51. PubMed ID: 17074791 [TBL] [Abstract][Full Text] [Related]
13. Interactions between anthrax toxin receptors and protective antigen. Scobie HM; Young JA Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864 [TBL] [Abstract][Full Text] [Related]
14. Tumor endothelial marker 8 amplifies canonical Wnt signaling in blood vessels. Verma K; Gu J; Werner E PLoS One; 2011; 6(8):e22334. PubMed ID: 21829615 [TBL] [Abstract][Full Text] [Related]
15. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor. Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881 [TBL] [Abstract][Full Text] [Related]
16. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability. Mamillapalli S; Miyagi M; Bann JG Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231 [TBL] [Abstract][Full Text] [Related]
17. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Bonuccelli G; Sotgia F; Frank PG; Williams TM; de Almeida CJ; Tanowitz HB; Scherer PE; Hotchkiss KA; Terman BI; Rollman B; Alileche A; Brojatsch J; Lisanti MP Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1402-10. PubMed ID: 15689409 [TBL] [Abstract][Full Text] [Related]
18. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Lacy DB; Wigelsworth DJ; Scobie HM; Young JA; Collier RJ Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6367-72. PubMed ID: 15079089 [TBL] [Abstract][Full Text] [Related]
20. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor. Dawson RM J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]